Company Information

Location

Paris, France

CEO

David Meek

Website

www.ipsen.com

The group develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neurosciences and Rare Diseases. Its commitment to oncology isexemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer.

Arix has a strategic partnership with Ipsen to develop and commercialise innovative therapies. Ipsen will gain access to Arix’s network of professional and scientific advisors, and the chance to invest in opportunities in Arix's new and existing businesses. In return, Ipsen will contribute research, development, and commercial expertise to the partnership. Arix and Ipsen will collaborate to identify opportunities and jointly create new companies focused primarily on the development and commercialisation of innovative therapies for patients.

Our Partners

Learn more about our other partners.